Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
Clinical trial NCT03153410 · COMPLETED
Trial details
- NCT number
- NCT03153410
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-27
- Primary completion
- 2022-03-09
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.